(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

MÉTODOS DE TRATAMENTO DE INFECÇÕES VIRAIS POR INFLUENZA E POXVÍRUS

ArquivadaInvention PatentPCT · US2023017943

Application data

Invention Patent MÉTODOS DE TRATAMENTO DE INFECÇÕES VIRAIS POR INFLUENZA E POXVÍRUS de VERU INC. — IPC A61K 31/4174
Invention Patent MÉTODOS DE TRATAMENTO DE INFECÇÕES VIRAIS POR INFLUENZA E POXVÍRUS de VERU INC. — IPC A61K 31/4174. Drawing published by the INPI in the Industrial Property Gazette.

Number

112024020457

Type

Invention Patent

Filing

04/07/2023

Publication

01/14/2025

PCT

US2023017943

Progress at the INPI

  1. Filing04/07/23
  2. Publication01/14/25
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 04/07/2023 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 06/30/2026. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

VERU INC.

US

Inventors

K. B. (pessoa física)

US

M. S. (pessoa física)

US

Technical data

Priority claims

US

63/328,504 · 04/07/2022

US

63/394,260 · 08/01/2022

US

63/456,943 · 04/04/2023

Abstract

MÉTODOS DE TRATAMENTO DE INFECÇÕES VIRAIS POR INFLUENZA E POXVÍRUS A presente invenção refere-se a métodos de tratamento de infecções virais específicas usando compostos tendo atividade antitubulina ou de desregulação de tubulina.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

06/30/2026

RPI 2895

Arquivamento - Art. 33 da LPI

#11.1

04/14/2026

RPI 2884

Notificação de entrada na fase nacional - PCT

#1.3

01/14/2025

RPI 2819

Alteração de dados cadastrais

#1.1

10/15/2024

RPI 2806

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.